Results 41 to 50 of about 9,082,977 (268)

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Research Data Management in the Croatian Academic Community: A Research Study

open access: yesPublications
This paper presents the results of an empirical research study of Croatian scientists’ use and management of research data. This research study was carried out from 28 June 2023 until 31 August 2023 using an online questionnaire consisting of 28 ...
Radovan Vrana
doaj   +1 more source

Neue Kompetenzen, neue Handlungsfelder und erweiterte Spielräume. Forschungsunterstützende Services an der UB Wien

open access: yesGMS Medizin – Bibliothek – Information, 2023
This article provides an overview of the history and development of research support services at the Vienna University Library, which began in 2008 with the operation of a publication and data repository.
Blumesberger, Susanne
doaj   +1 more source

Research priorities for data collection and management within global acute and emergency care systems. [PDF]

open access: yes, 2013
Barriers to global emergency care development include a critical lack of data in several areas, including limited documentation of the acute disease burden, lack of agreement on essential components of acute care systems, and a lack of consensus on key ...
Bisanzo, Mark   +7 more
core   +2 more sources

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Towards a generic research data management infrastructure [PDF]

open access: yes, 2010
Until recent years, a focused and centralized strategy for the annotation, storage and curation of research data is something that has not been widely considered within academic communities.
Beard, Lorraine   +9 more
core  

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Study on Damage Evolution Model of Sandstone under Triaxial Loading and Postpeak Unloading Considering Nonlinear Behaviors

open access: yesGeofluids, 2021
Conventional triaxial loading and unloading tests were carried out on sandstone samples in the Zigong area, of Sichuan Province, China. The changes in the elastic modulus of the unloading curves under different confining pressures were calculated, and ...
Tianbai Zhou   +4 more
doaj   +1 more source

Data Management Plans in Horizon 2020: what beneficiaries think and what we can learn from their experience [version 2; peer review: 2 approved, 1 approved with reservations]

open access: yesOpen Research Europe, 2022
Background: Data Management Plans (DMPs) are at the heart of many research funder requirements for data management and open data, including the EU’s Framework Programme for Research and Innovation, Horizon 2020.
Daniel Spichtinger
doaj   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy